FDA 483 - Robert Clark Brown, MD, PhD - August 20, 2021

An FDA inspection of Robert Clark Brown, MD, PhD in Atlanta, GA, revealed significant deficiencies in clinical investigation conduct. The firm failed to follow its investigational plan by not completing required safety laboratory assessments for a majority of enrolled subjects. Additionally, the firm did not promptly report numerous protocol deviations, including missed safety labs, to the IRB as required.